Surface Pharmaceuticals
Updated: August 03, 2025

Kamran Hosseini, President & CEO
Country: USA | Funding: $46.8M (+)
Website: http://surfacepharma.com/
Surface Pharmaceuticals intends to advance state of the art treatments for ocular surface diseases.
Website: http://surfacepharma.com/
Surface Pharmaceuticals intends to advance state of the art treatments for ocular surface diseases.





